Search research articles
Contact Us
Filters
Showing results (11-20 of 178) with videos related to
Page
of 18
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prognostic factors for complete debulking in first- and second-line ovarian cancer
Philipp Harter, Felix Hilpert, Sven Mahner, et al.
Gynecologic Oncology
|
October 15, 2014
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Cancer
|
January 23, 2020
How to manage lymph nodes in ovarian cancer
Philipp Harter, Florian Heitz, Beyhan Ataseven, et al.
Gynecologic Oncology
|
December 23, 2015
Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Plos One
|
May 29, 2015
Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis
Nina Buttmann-Schweiger, Stefanie J Klug, Alexander Luyten, et al.
Gynecologic Oncology
|
March 19, 2013
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
Florian Heitz, Andreas du Bois, Philipp Harter, et al.
Women'S Health (London, England)
|
September 2, 2011
Surgery for recurrent ovarian cancer
Florian Heitz, Andreas du Bois, Christian Kurzeder, et al.
Geburtshilfe Und Frauenheilkunde
|
October 27, 2018
Low-grade Serous Ovarian Carcinoma
Enzo Ricciardi, Thaïs Baert, Beyhan Ataseven, et al.
Gynecologic Oncology
|
April 5, 2012
Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer
Jacek P Grabowski, Philipp Harter, Rita Hils, et al.
Advances in Therapy
|
September 4, 2012
Bevacizumab in the treatment of ovarian cancer
Florian Heitz, Philipp Harter, Jana Barinoff, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 178) with videos related to
Sort By:
Page
of 18
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prognostic factors for complete debulking in first- and second-line ovarian cancer
Philipp Harter, Felix Hilpert, Sven Mahner, et al.
Gynecologic Oncology
|
October 15, 2014
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Cancer
|
January 23, 2020
How to manage lymph nodes in ovarian cancer
Philipp Harter, Florian Heitz, Beyhan Ataseven, et al.
Gynecologic Oncology
|
December 23, 2015
Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Plos One
|
May 29, 2015
Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis
Nina Buttmann-Schweiger, Stefanie J Klug, Alexander Luyten, et al.
Gynecologic Oncology
|
March 19, 2013
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
Florian Heitz, Andreas du Bois, Philipp Harter, et al.
Women'S Health (London, England)
|
September 2, 2011
Surgery for recurrent ovarian cancer
Florian Heitz, Andreas du Bois, Christian Kurzeder, et al.
Geburtshilfe Und Frauenheilkunde
|
October 27, 2018
Low-grade Serous Ovarian Carcinoma
Enzo Ricciardi, Thaïs Baert, Beyhan Ataseven, et al.
Gynecologic Oncology
|
April 5, 2012
Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer
Jacek P Grabowski, Philipp Harter, Rita Hils, et al.
Advances in Therapy
|
September 4, 2012
Bevacizumab in the treatment of ovarian cancer
Florian Heitz, Philipp Harter, Jana Barinoff, et al.
Page
of 18